The Effects of Minor Non-Disabling Stroke on Clinical Practice

Major non-disabling stroke was defined in the Aramis trial as patients who presented with Acute Aschemic Stroke with an NIH stroke scale of five or less. Patients had to have one point or less on the NIH single item scores such as motor, vision, language, neglect and you couldn't score in the consciousness item. So if these patients met these criteria they were automatically considered for the trial.